CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hainan Shuangcheng Pharmaceuticals Co Ltd Company Snapshot
Hainan Shuangcheng Pharmaceuticals Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hainan Shuangcheng Pharmaceuticals Co Ltd with three other companies in this sector in CHINA : Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. (2019 sales of 297.07 million Chinese Renmimbi [US$43.53 million] of which 71% was Medicine), Zhejiang Ausun Pharmaceutical Co Ltd (307.69 million Chinese Renmimbi [US$45.09 million] of which 37% was Antibacterial Products), and Tus-Guhan Group Corp Ltd (315.03 million Chinese Renmimbi [US$46.17 million] of which 91% was TCM and Tonics Manufacturing).

Sales Analysis. During the year ended December of 2019, sales at Hainan Shuangcheng Pharmaceuticals Co Ltd were 346.65 million Chinese Renmimbi (US$50.80 million). This is an increase of 2.8% versus 2018, when the company's sales were 337.24 million Chinese Renmimbi. This was the third consecutive year of growth at Hainan Shuangcheng Pharmaceuticals Co Ltd. Sales of Agent Medicines Business saw an increase that was more than double the company's growth rate: sales were up 13.8% in 2019, from 79.99 million Chinese Renmimbi to 91.00 million Chinese Renmimbi. Not all segments of Hainan Shuangcheng Pharmaceuticals Co Ltd experienced an increase in sales in 2019: sales of Other Business fell 64.3% to 5.45 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hainan Shuangcheng Pharmaceuticals Co Ltd
  Stock Performance Chart for Hainan Shuangcheng Pharmaceuticals Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 5.00
(Figures in Chinese Renmimbi)
1 Week -5.5%   13 Weeks -7.1%  
4 Weeks -1.2%   52 Weeks 8.7%  
 
Hainan Shuangcheng Pharmaceuticals Co Ltd Key Data:
  Ticker: 002693 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 346,648,799
(Year Ending Jan 2020).
Employees: 353
  Currency: Chinese Renmimbi Market Cap: 2,025,000,000
  Fiscal Yr Ends: December Shares Outstanding: 405,000,000
  Share Type: A Gu Closely Held Shares: 225,169,890
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.